Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Roivant Sciences's Reporting person sold $3.11M of Roivant Sciences shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 10, 2026 · Filed Nov 13, 2026
The CEO of Roivant Sciences sold $1.22M of Roivant Sciences shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$1,219,709
Shares × reported transaction price
1 day after results of Nov 9, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $41.19 on Nov 10, 2026, within 2% of its 52-week high, after a 13% rise over the previous 30 trading days
52-week range $20.10 (Dec 2, 2025) to $41.81 (Sep 9, 2026), 97% of the way up, from 251 adjusted closes. 30 trading days earlier: $36.50 on Sep 29, 2026. Describes the past only, not a forecast
RSI 66, 29% above its 200-day average, 12% above its 50-day average, 1% below the 52-week high, 20-day volatility 46% a year, against the S&P 500: +23 points over 1 month, +17 points over 3 months, +39 points over 6 months
From the adjusted closes up to Nov 10, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −2.2% | −8.6% | +6.3% |
Past results only. Not a forecast.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Roivant Sciences's Reporting person sold $3.11M of Roivant Sciences shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Roivant Sciences's Reporting person sold $21.6M of Roivant Sciences shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Roivant Sciences's Reporting person sold $738K of Roivant Sciences shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.